Color: Funding, Investors & Team (Sep 2026)

Color is a population health technology company that focuses on providing large-scale health care programs and clinical testing. It improves the key health infrastructure systems to make health accessible, convenient, and cost-effective, serving health systems, employers, research institutions, and individual consumers. Its Population Genomics Platform offers modular and end-to-end solutions that enable organizations to effectively build and scale population health programs. It provides technology, software, and clinical services to help population programs launch and scale quickly. By combining innovative technology, specialized laboratory infrastructure, and clinical health services, Color creates complete and effective programs that include: Program strategy, planning, and implementation; Participant outreach and engagement; participant education and consent about testing and results; sample (blood or saliva) collection and genetic sequencing; data management and clinical reporting; HIPAA compliance and data security; return of results; clinical services, like genetic counseling and clinical pharmacy; personalized care routine; and ongoing population health management. Color’s partners include NorthShore University Health System, the National Institutes of Health (NIH), Ochsner Health System, Verily, Visa, Levi Strauss, and Salesforce. Elad Gil, Nish Bhat, Taylor Sittler, and Othman Laraki launched Color in 2015 and is based in Burlingame, California.

Color has raised $267M across 2 rounds on record. The most recent is a Series E of $100M announced in Nov 2021.

Color's most recent funding round on record is a Series E of $100M, announced in Nov 2021.

Elad Gil is listed as CEO at Color.

Color is based in Burlingame, California, United States.

Color is in the 501-1000 employee band.

Color's latest round of $100M is above the $4.1M median round size for Apps companies on FundedIQ across 2,426 tracked companies over the last two years.